1. Home
  2. UG vs DXR Comparison

UG vs DXR Comparison

Compare UG & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • DXR
  • Stock Information
  • Founded
  • UG 1942
  • DXR 1970
  • Country
  • UG United States
  • DXR United States
  • Employees
  • UG N/A
  • DXR N/A
  • Industry
  • UG Package Goods/Cosmetics
  • DXR Medical/Dental Instruments
  • Sector
  • UG Consumer Discretionary
  • DXR Health Care
  • Exchange
  • UG Nasdaq
  • DXR Nasdaq
  • Market Cap
  • UG 36.9M
  • DXR 36.4M
  • IPO Year
  • UG N/A
  • DXR N/A
  • Fundamental
  • Price
  • UG $8.07
  • DXR $9.75
  • Analyst Decision
  • UG
  • DXR Strong Buy
  • Analyst Count
  • UG 0
  • DXR 1
  • Target Price
  • UG N/A
  • DXR $25.00
  • AVG Volume (30 Days)
  • UG 3.7K
  • DXR 6.0K
  • Earning Date
  • UG 08-08-2025
  • DXR 01-01-0001
  • Dividend Yield
  • UG 8.60%
  • DXR N/A
  • EPS Growth
  • UG 4.93
  • DXR 86.16
  • EPS
  • UG 0.63
  • DXR 0.11
  • Revenue
  • UG $11,408,154.00
  • DXR $119,714.00
  • Revenue This Year
  • UG N/A
  • DXR N/A
  • Revenue Next Year
  • UG N/A
  • DXR N/A
  • P/E Ratio
  • UG $12.78
  • DXR $88.78
  • Revenue Growth
  • UG N/A
  • DXR N/A
  • 52 Week Low
  • UG $7.73
  • DXR $6.55
  • 52 Week High
  • UG $16.25
  • DXR $10.00
  • Technical
  • Relative Strength Index (RSI)
  • UG 44.82
  • DXR 64.29
  • Support Level
  • UG $7.94
  • DXR $8.68
  • Resistance Level
  • UG $8.21
  • DXR $9.03
  • Average True Range (ATR)
  • UG 0.15
  • DXR 0.50
  • MACD
  • UG -0.01
  • DXR 0.02
  • Stochastic Oscillator
  • UG 23.21
  • DXR 91.22

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: